IGC Pharma, Inc. (IGC): Operating Cash Flow

Annual figures by period end, from SEC filings.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$4.79M
Year ended 2025-03-31
-$5.54M
Trailing 12 months to 2025-09-30
$564.8K2011-03-31: -$2.63M2012-03-31: -$5.02M2013-03-31: $564.8K2014-03-31: -$1.74M2015-03-31: -$2.58M2016-03-31: -$157.7K2017-03-31: -$1.39M2018-03-31: -$1.93M2019-03-31: -$3.33M2020-03-31: -$8.68M2021-03-31: -$10.80M2022-03-31: -$7.46M2023-03-31: -$7.05M2024-03-31: -$5.20M2025-03-31: -$4.79M-$4.79M
2011-03-31 Operating Cash Flow (USD) 2025-03-31
Period endedOperating Cash FlowChange YoYSource filing
2025-03-31-$4.79Mn/m2025-06-27, From 2024-04-01
2024-03-31-$5.20Mn/m2025-06-27, From 2023-04-01
2023-03-31-$7.05Mn/m2024-06-24, From 2022-04-01
2022-03-31-$7.46Mn/m2023-07-07, From 2021-04-01
2021-03-31-$10.80Mn/m2022-06-23, From 2020-04-01
2020-03-31-$8.68Mn/m2021-06-14, From 2019-04-01
2019-03-31-$3.33Mn/m2020-07-13, From 2018-04-01
2018-03-31-$1.93Mn/m2019-06-14, From 2017-04-01
2017-03-31-$1.39Mn/m2018-06-21, From 2016-04-01
2016-03-31-$157.7Kn/m2017-07-14, From 2015-04-01
2015-03-31-$2.58Mn/m2016-07-14, From 2014-04-01
2014-03-31-$1.74Mn/m2015-07-14, From 2013-04-01
2013-03-31$564.8Kn/m2014-07-15, From 2012-04-01
2012-03-31-$5.02Mn/m2014-07-15, From 2011-04-01
2011-03-31-$2.63Mn/a2012-07-16, From 2010-04-01